CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 9 enrolled
Drug / intervention
Prednisone +1 moredrug
Likely dose
Prednisone 20mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00890617
NCT00890617Phase 1Completed
CompareCT.gov

A Pilot Study of Percutaneous Cryotherapy as Treatment for Stage I Lung Cancer or Solitary Metastatic Lung Cancer

Barbara Ann Karmanos Cancer Institute·interventional·Posted Apr 30, 2009·Updated Nov 1, 2022

In Brief

A Phase 1 clinical trial evaluating Cryotherapy (PTC) and Prednisone for Lung Cancer and Metastatic Cancer. Completed, enrolled 9 participants across 1 site.

Detailed Summary

RATIONALE: Cryotherapy kills tumor cells by freezing them. Giving cryotherapy before surgery may kill more tumor cells. PURPOSE: This phase I trial is studying how well cryotherapy works in treating patients with primary stage I non-small cell lung cancer or lung metastasis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer, Metastatic Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 1CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 30, 2009
Enrollment StartMar 1, 2009
Primary CompletionJul 27, 2019
Study CompletionMay 1, 2021
TodayJul 2, 2026
Enrollment to primary: 10.4 yearsPosted 17.2 years ago

Interventions

Cryotherapy (PTC)procedure

CT-guided PTC with the intent to eradicate the entire tumor(s).

Prednisonedrug

Prednisone taken: 20mg BID on the day of the cryotherapy procedure 20mg BID on the day after the procedure 20mg BID two days after the procedure 20mg AM and 10mg PM three days after the procedure 10mg AM and 10mg PM four days after the procedure 10mg five days after the procedure 5mg six days after the procedure